vs
Side-by-side financial comparison of Falcon's Beyond Global, Inc. (FBYD) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
Falcon's Beyond Global, Inc. is the larger business by last-quarter revenue ($6.6M vs $5.5M, roughly 1.2× Taysha Gene Therapies, Inc.). Falcon's Beyond Global, Inc. runs the higher net margin — -4.5% vs -507.8%, a 503.3% gap on every dollar of revenue. On growth, Falcon's Beyond Global, Inc. posted the faster year-over-year revenue change (383.5% vs 171.3%). Over the past eight quarters, Falcon's Beyond Global, Inc.'s revenue compounded faster (108.4% CAGR vs 26.8%).
500 Global is an early-stage venture fund and seed accelerator founded in 2010 by Dave McClure and Christine Tsai. The fund admitted a first "class" of twelve startups to its incubator office in Mountain View, California in February 2011. They expanded to a second class of 21 in June 2011 and a third class of 34 in October 2011. 500 Global has $2.3 billion in assets under management (AUM) as of March 2024.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
FBYD vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.6M | $5.5M |
| Net Profit | $-296.0K | $-27.9M |
| Gross Margin | — | — |
| Operating Margin | -30.9% | -516.0% |
| Net Margin | -4.5% | -507.8% |
| Revenue YoY | 383.5% | 171.3% |
| Net Profit YoY | 97.5% | -48.3% |
| EPS (diluted) | $-0.01 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.6M | $5.5M | ||
| Q3 25 | $4.1M | $0 | ||
| Q2 25 | $2.5M | $2.0M | ||
| Q1 25 | $1.7M | $2.3M | ||
| Q4 24 | $1.4M | $2.0M | ||
| Q3 24 | $2.1M | $1.8M | ||
| Q2 24 | $1.8M | $1.1M | ||
| Q1 24 | $1.5M | $3.4M |
| Q4 25 | $-296.0K | $-27.9M | ||
| Q3 25 | $-10.4M | $-32.7M | ||
| Q2 25 | $25.1M | $-26.9M | ||
| Q1 25 | $-8.1M | $-21.5M | ||
| Q4 24 | $-11.9M | $-18.8M | ||
| Q3 24 | $39.3M | $-25.5M | ||
| Q2 24 | $8.0M | $-20.9M | ||
| Q1 24 | $114.0M | $-24.1M |
| Q4 25 | -30.9% | -516.0% | ||
| Q3 25 | -90.9% | — | ||
| Q2 25 | -53.0% | -1347.1% | ||
| Q1 25 | -371.1% | -930.5% | ||
| Q4 24 | -335.6% | -985.8% | ||
| Q3 24 | -118.9% | -1448.4% | ||
| Q2 24 | -195.9% | -1915.4% | ||
| Q1 24 | -350.5% | -713.3% |
| Q4 25 | -4.5% | -507.8% | ||
| Q3 25 | -256.8% | — | ||
| Q2 25 | 985.2% | -1353.6% | ||
| Q1 25 | -473.8% | -935.2% | ||
| Q4 24 | -871.7% | -929.0% | ||
| Q3 24 | 1899.5% | -1427.5% | ||
| Q2 24 | 446.5% | -1882.0% | ||
| Q1 24 | 7521.4% | -705.4% |
| Q4 25 | $-0.01 | $-0.08 | ||
| Q3 25 | $-0.13 | $-0.09 | ||
| Q2 25 | $0.30 | $-0.09 | ||
| Q1 25 | $-0.13 | $-0.08 | ||
| Q4 24 | $-0.25 | $-0.07 | ||
| Q3 24 | $0.39 | $-0.10 | ||
| Q2 24 | $0.00 | $-0.09 | ||
| Q1 24 | $1.27 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $319.8M |
| Total DebtLower is stronger | $15.6M | — |
| Stockholders' EquityBook value | $11.9M | $246.9M |
| Total Assets | $66.7M | $343.3M |
| Debt / EquityLower = less leverage | 1.31× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9M | $319.8M | ||
| Q3 25 | $4.3M | $297.3M | ||
| Q2 25 | $26.1M | $312.8M | ||
| Q1 25 | $1.1M | $116.6M | ||
| Q4 24 | $825.0K | $139.0M | ||
| Q3 24 | $828.0K | $157.7M | ||
| Q2 24 | $1.7M | $172.7M | ||
| Q1 24 | $1.1M | $124.0M |
| Q4 25 | $15.6M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $41.2M | — | ||
| Q3 24 | $10.3M | — | ||
| Q2 24 | $15.7M | — | ||
| Q1 24 | $15.1M | — |
| Q4 25 | $11.9M | $246.9M | ||
| Q3 25 | $9.2M | $219.0M | ||
| Q2 25 | $414.0K | $248.7M | ||
| Q1 25 | $-11.6M | $55.1M | ||
| Q4 24 | $-9.0M | $71.5M | ||
| Q3 24 | $-1.4M | $88.8M | ||
| Q2 24 | $-44.7M | $108.9M | ||
| Q1 24 | $-61.7M | $53.8M |
| Q4 25 | $66.7M | $343.3M | ||
| Q3 25 | $66.8M | $316.6M | ||
| Q2 25 | $89.2M | $333.3M | ||
| Q1 25 | $56.7M | $138.4M | ||
| Q4 24 | $61.2M | $160.4M | ||
| Q3 24 | $66.5M | $180.2M | ||
| Q2 24 | $65.9M | $200.4M | ||
| Q1 24 | $67.8M | $153.0M |
| Q4 25 | 1.31× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.3M | $-26.7M |
| Free Cash FlowOCF − Capex | $-4.3M | — |
| FCF MarginFCF / Revenue | -66.0% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.3M | $-26.7M | ||
| Q3 25 | $-13.3M | $-24.2M | ||
| Q2 25 | $-7.9M | $-20.2M | ||
| Q1 25 | $945.0K | $-22.0M | ||
| Q4 24 | $-3.8M | $-18.3M | ||
| Q3 24 | $-2.4M | $-21.6M | ||
| Q2 24 | $-2.6M | $-21.5M | ||
| Q1 24 | $-3.8M | $-19.8M |
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $-13.4M | $-24.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | $853.0K | — | ||
| Q4 24 | $-3.8M | $-18.3M | ||
| Q3 24 | $-2.4M | $-21.6M | ||
| Q2 24 | $-2.6M | $-21.7M | ||
| Q1 24 | $-3.8M | $-19.9M |
| Q4 25 | -66.0% | — | ||
| Q3 25 | -329.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 49.9% | — | ||
| Q4 24 | -278.7% | -905.5% | ||
| Q3 24 | -114.9% | -1210.9% | ||
| Q2 24 | -145.6% | -1951.9% | ||
| Q1 24 | -248.8% | -584.5% |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 0.1% | 0.1% | ||
| Q3 24 | 0.2% | 2.0% | ||
| Q2 24 | 0.1% | 18.1% | ||
| Q1 24 | 0.3% | 4.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.06× | — | ||
| Q2 24 | -0.33× | — | ||
| Q1 24 | -0.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
